Innate Pharma SA Increase Decrease Through Appropriation Of Retained Earnings
Innate Pharma SA (IPHA) reported Increase Decrease Through Appropriation Of Retained Earnings of EUR 0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughAppropriationOfRetainedEarnings · last filed 2026-04-01
| Period end | Increase Decrease Through Appropriation Of Retained Earnings 6 month | Increase Decrease Through Appropriation Of Retained Earnings 12 month |
|---|---|---|
| 2025-12-31 | 0.00 EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 0.00 EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 0.00 EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 0.00 EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 0.00 EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 0.00 EUR 6-K · filed 2024-09-12 | |
| 2022-06-30 | 0.00 EUR 6-K · filed 2023-09-14 | |
| 2021-06-30 | 0.00 EUR 6-K · filed 2022-09-15 |